AMHR2 and lung adenocarcinoma: Owing to the lack of AMHR2‐positive cases in lung squamous cell carcinoma tissues, we investigated the association between AMHR2 immunoreactivity and the clinicopathological features of lung adenocarcinoma cases (Table 1).